Marlyn sells SHPG 251.81: The Zacks Analyst Blog Highlights: AbbVie, Shire, Amgen, InterMune and Biogen
Stocks recently featured in the blog includethe AbbVie (NYSE:ABBV-Free Report), Shire (Nasdaq:SHPG-Free Report), Amgen (Nasdaq:AMGN-Free Report), InterMune (Nasdaq:ITMN-Free Report) and Biogen (Nasdaq:BIIB-Free Report). Today, Zacks is promoting its 'Buy . ... ...
57 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home